Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

176
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
176
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

228
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
228
Bipolar Disorder01:30

Bipolar Disorder

67
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
67
Depression: Overview01:18

Depression: Overview

242
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
242
Diagnostic and Statistical Manual of Mental Disorders (DSM)01:27

Diagnostic and Statistical Manual of Mental Disorders (DSM)

55
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
55
Language and Cognition01:27

Language and Cognition

345
Language serves as a bridge between ideas and communication, influencing how individuals perceive and interact with the world. Psychologists have long debated whether language shapes thought or vice versa. This discussion gained grip with Edward Sapir and Benjamin Lee Whorf in the 1940s, who proposed that language determines thought, a concept known as linguistic determinism. They suggested that the vocabulary and structure of a language influence how its speakers think and perceive reality.
345

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Establishing a Specialty Bipolar Clinic: The National Network of Depression Centers Consensus Recommendations.

Bipolar disorders·2026
Same author

Nephroprotective Effects of GLP-1 Receptor Agonists in Lithium-Treated Patients: A Multinational Cohort Study Using the TriNetX Network.

CNS spectrums·2026
Same author

Progress on Pharmacogenetic Tests for Antidepressant Drug Selection Requires Properly Designed Studies.

Journal of clinical psychopharmacology·2026
Same author

The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD<sup>✰</sup>.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same author

Adjunctive Antipsychotics in Major Depressive Disorder: A Systematic Review and Network Meta-Analysis.

JAMA psychiatry·2026
Same author

Safety and Efficacy of Maintenance Treatment With Aripiprazole Once-Monthly in Black/African American Adults Diagnosed With Bipolar I Disorder: Post Hoc Analysis of a 52-Week, Open-Label Study.

The Journal of clinical psychiatry·2026

相关实验视频

Updated: Jul 1, 2025

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

555

用大型语言模型为双极性抑郁症提供临床决策支持.

Roy H Perlis1,2, Joseph F Goldberg3, Michael J Ostacher4

  • 1Center for Quantitative Health and Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA. rperlis@mgh.harvard.edu.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
|March 14, 2024
PubMed
概括
此摘要是机器生成的。

大型语言模型加上双相情感障碍指导方针,在支持抑郁症管理临床决策方面显示出有前途. 增强模型在50.8%的病例中与专家建议相匹配,优于非增强模型和社区临床医生.

更多相关视频

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

2.3K
Developing a Rat Model for Bipolar Disorder
04:44

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

258

相关实验视频

Last Updated: Jul 1, 2025

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

555
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

2.3K
Developing a Rat Model for Bipolar Disorder
04:44

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

258

科学领域:

  • 人工智能在医学中的应用
  • 临床决策支持系统 临床决策支持系统
  • 精神病学药物治疗 精神病学药物治疗

背景情况:

  • 管理双极性抑郁症是复杂的,治疗指南提供了一些指导.
  • 大型语言模型 (LLM) 显示出有助于临床决策的潜力.
  • 目前在双相情感障碍药物治疗中的LLM应用需要进一步调查.

研究的目的:

  • 评估LLM (GPT-4-turbo) 在确定双极性抑郁症最佳药物疗法的有效性.
  • 为了比较LLM增强的治疗指南与非增强的LLM的性能.
  • 根据专家建议和社区临床医生的准确性来评估LLM的表现.

主要方法:

  • 创建了50个双极性抑郁症的临床图片.
  • 双极性障碍专家确定了最佳和禁忌的药物治疗方法.
  • 一个LLM (GPT-4-turbo) 经过测试,在视频上有或没有指导方针增强.

主要成果:

  • 增强的LLM在50.8%的病例中确定了专家推的最佳治疗方法 (科恩的卡帕=0.31).
  • 未增强的LLM实现了23.0%的准确性,明显低于增强模型.
  • 增强的LLM绩效超过了社区临床医生 (23.1%的平均准确率).

结论:

  • 基于证据的指导方针促使LLM提供了一个可扩展的策略,用于临床决策支持双极性抑郁症.
  • 需要进一步的研究来验证疗效,并解决潜在的过度依赖和偏见.
  • 增强的LLM显示有可能改善双极性抑郁症的药物治疗选择精度.